Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andre Goy

Showing results (51-60 of 164) with videos related to

Pageof 17
Sort By:
Oncotarget|April 28, 2016
Mantle cell lymphoma in the era of precision medicine-diagnosis, biomarkers and therapeutic agentsArati A Inamdar, Andre Goy, Nehad M Ayoub, et al.
Haematologica|November 17, 2018
Ibrutinib for the treatment of relapsed/refractory mantle cell lymphoma: extended 3.5-year follow up from a pooled analysisSimon Rule, Martin Dreyling, Andre Goy, et al.
Heliyon|May 30, 2023
Combining cell-free RNA with cell-free DNA in liquid biopsy for hematologic and solid tumorsMaher Albitar, Hong Zhang, Ahmad Charifa, et al.
Cancer|September 16, 2003
Intensive chemotherapy with cyclophosphamide, doxorubicin, high-dose methotrexate/ifosfamide, etoposide, and high-dose cytarabine (CODOX-M/IVAC) for human immunodeficiency virus-associated Burkitt lymphomaEunice S Wang, David J Straus, Julie Teruya-Feldstein, et al.
Clinical Lymphoma, Myeloma & Leukemia|June 18, 2017
Treatment of Peripheral T-Cell Lymphoma in Community SettingsTatyana Feldman, Charles M Farber, Kelly Choi, et al.
Oncotarget|February 9, 2017
Protein calorie malnutrition, nutritional intervention and personalized cancer careAnju Gangadharan, Sung Eun Choi, Ahmed Hassan, et al.
Leukemia & Lymphoma|September 14, 2004
Establishment and characterization of a new mantle cell lymphoma cell line M-1Andre Goy, Yvonne K Remache, Jun Gu, et al.
Cancer|April 16, 2011
Higher response to lenalidomide in relapsed/refractory diffuse large B-cell lymphoma in nongerminal center B-cell-like than in germinal center B-cell-like phenotypeFrancisco J Hernandez-Ilizaliturri, George Deeb, Pier L Zinzani, et al.
Blood Advances|October 19, 2022
Toxicity and efficacy of CAR T-cell therapy in primary and secondary CNS lymphoma: a meta-analysis of 128 patientsMichael R Cook, C Scott Dorris, Kepher H Makambi, et al.
Leukemia & Lymphoma|March 9, 2019
Clinical impact of Internet-based tools to guide therapeutic decisions for mantle cell lymphomaSrinivasa N Gopalsamy, Kristen M Rosenthal, Amy A Ayers, et al.
Pageof 17

Showing results (51-60 of 164) with videos related to

Sort By:
Pageof 17
Oncotarget|April 28, 2016
Mantle cell lymphoma in the era of precision medicine-diagnosis, biomarkers and therapeutic agentsArati A Inamdar, Andre Goy, Nehad M Ayoub, et al.
Haematologica|November 17, 2018
Ibrutinib for the treatment of relapsed/refractory mantle cell lymphoma: extended 3.5-year follow up from a pooled analysisSimon Rule, Martin Dreyling, Andre Goy, et al.
Heliyon|May 30, 2023
Combining cell-free RNA with cell-free DNA in liquid biopsy for hematologic and solid tumorsMaher Albitar, Hong Zhang, Ahmad Charifa, et al.
Cancer|September 16, 2003
Intensive chemotherapy with cyclophosphamide, doxorubicin, high-dose methotrexate/ifosfamide, etoposide, and high-dose cytarabine (CODOX-M/IVAC) for human immunodeficiency virus-associated Burkitt lymphomaEunice S Wang, David J Straus, Julie Teruya-Feldstein, et al.
Clinical Lymphoma, Myeloma & Leukemia|June 18, 2017
Treatment of Peripheral T-Cell Lymphoma in Community SettingsTatyana Feldman, Charles M Farber, Kelly Choi, et al.
Oncotarget|February 9, 2017
Protein calorie malnutrition, nutritional intervention and personalized cancer careAnju Gangadharan, Sung Eun Choi, Ahmed Hassan, et al.
Leukemia & Lymphoma|September 14, 2004
Establishment and characterization of a new mantle cell lymphoma cell line M-1Andre Goy, Yvonne K Remache, Jun Gu, et al.
Cancer|April 16, 2011
Higher response to lenalidomide in relapsed/refractory diffuse large B-cell lymphoma in nongerminal center B-cell-like than in germinal center B-cell-like phenotypeFrancisco J Hernandez-Ilizaliturri, George Deeb, Pier L Zinzani, et al.
Blood Advances|October 19, 2022
Toxicity and efficacy of CAR T-cell therapy in primary and secondary CNS lymphoma: a meta-analysis of 128 patientsMichael R Cook, C Scott Dorris, Kepher H Makambi, et al.
Leukemia & Lymphoma|March 9, 2019
Clinical impact of Internet-based tools to guide therapeutic decisions for mantle cell lymphomaSrinivasa N Gopalsamy, Kristen M Rosenthal, Amy A Ayers, et al.
Pageof 17